Decreases in pain at rest and movement-related pain during zoledronic acid treatment in patients with bone metastases due to breast or prostate cancer: a pilot study

By Ripamonti Carla  

Supportive Care in Cancer, Vol. 15, Iss. 10, 2007-10 ,pp. : 1177-1184

Springer Publishing Company

Access to resources Recommend Favorite

Pain Control with Zoledronic Acid in Patients with Breast Cancer and Metastatic Bone Disease

By Cinzia Nigro   Michela Donadio   Mara Ardine   Alessandra Beano   Marinella Mistrangelo   Zaira Coccorullo   Oscar Bertetto  

American Journal of Cancer, Vol. 3, Iss. 4, 2004-01 ,pp. : 257-263

Adis International

Access to resources Recommend Favorite

Higher Incidence of Osteonecrosis of the Jaw (ONJ) in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Anti-Angiogenic Agents

By Aragon-Ching Jeanny   Ning Yang-Min   Chen Clara   Latham Lea   Guadagnini Jean-Pierre   Gulley James   Arlen Philip   Wright John   Parnes Howard   Figg William   Dahut William  

Cancer Investigation, Vol. 27, Iss. 2, 2009-02 ,pp. : 221-226

Informa Healthcare

Access to resources Recommend Favorite

Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: A retrospective analysis

By Ortega Cinzia   Montemurro Filippo   Faggiuolo Roberto   Vormola Roberto   Nanni Daniela   Goia Franco   Gilardino Marco Ottavio   Aglietta Massimo  

Acta Oncologica, Vol. 46, Iss. 5, 2007-01 ,pp. : 664-668

Informa Healthcare

Access to resources Recommend Favorite

Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance

By Zhao Xinmin  

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 733-743

Springer Publishing Company

Access to resources Recommend Favorite